Items where authors include "Quayle, L.A."
Article
Morita, M., Arshad, F., Quayle, L.A. et al. (8 more authors) (2024) Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse model. Bone Reports, 22. 101795. ISSN 2352-1872
Griffin, J. orcid.org/0000-0003-3969-7637, Down, J., Quayle, L.A. et al. (10 more authors) (2024) Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial. The Journal of Pathology: Clinical Research, 10 (2). e12363. ISSN 2056-4538
Catto, J.W.F. orcid.org/0000-0003-2787-8828, Mandrik, O. orcid.org/0000-0003-3755-3031, Quayle, L.A. et al. (12 more authors) (2023) Diagnosis, treatment and survival from bladder, upper urinary tract and urethral cancers: real-world findings from NHS England between 2013 and 2019. BJU International, 131 (6). pp. 734-744. ISSN 1464-4096
Quayle, L.A., Spicer, A., Ottewell, P.D. et al. (1 more author) (2021) Transcriptomic profiling reveals novel candidate genes and signalling programs in breast cancer quiescence and dormancy. Cancers, 13 (16). 3922.
Tulotta, C., Lefley, D.V., Moore, C.K. et al. (13 more authors) (2021) IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. npj Breast Cancer, 7 (1). 95.
Quayle, L.A., Ottewell, P.D. orcid.org/0000-0002-4826-0771 and Holen, I. orcid.org/0000-0002-8759-6913 (2018) Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention. Clinical & Experimental Metastasis, 35 (8). pp. 831-846. ISSN 0262-0898
Quayle, L.A., Pereira, M.G., Scheper, G. et al. (5 more authors) (2017) Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action. Oncotarget, 8 (51). pp. 88670-88688.
Book Section
Ottewell, P.D. orcid.org/0000-0002-4826-0771 and Quayle, L.A. (2019) Tumor dormancy in the bone. In: Reference Module in Biomedical Sciences. Elsevier . ISBN 978-0-12-801238-3